ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-p15 INK4b Antibody [DCS-114.1] (A280230)

This product is discontinued

Anti-p15 INK4b Antibody [DCS-114.1] (A280230) has been discontinued and is no longer available.

View all p15 INK4b Antibodies.

Name
Anti-p15 INK4b Antibody [DCS-114.1]
Description
Mouse monoclonal [DCS-114.1] antibody to p15 INK4b.
Specificity
This antibody recognises human p15-Ink4b, also known as Cyclin-dependent kinase 4 inhibitor B or Multiple tumor suppressor 2. p15-Ink4b is a 138 amino acid, ~15 kDa cytoplasmic tumor suppressor protein which inhibits the cyclin D dependent kinases cdk4/6.
Applications
WB, IP, IHC-Fr
Reactivity
Human
Immunogen
Full length recombinant p15 His tagged.
Host
Mouse
Clonality
Monoclonal
Clone ID
DCS-114.1
Isotype
IgG1
Conjugate

Unconjugated

Concentration
1 mg/ml
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline with 0.08% Sodium Azide.
Storage
Shipped at ambient temperature. Upon delivery aliquot and store at -20°C. When thawed, aliquot the sample as needed. Short term (up to 4 weeks): store at 4°C. Long term: store at -20°C. Avoid freeze / thaw cycles. Storage in frost free freezers is not recommended.
General Notes
Mouse anti Human p15 antibody, clone DCS-114.1 recognises human p15-Ink4b, also known as Cyclin-dependent kinase 4 inhibitor B or Multiple tumor suppressor 2. p15-Ink4b is a 138 amino acid, ~15 kDa cytoplasmic tumor suppressor protein which inhibits the cyclin D dependent kinases cdk4/6.
Synonyms
CDKN2B, Cyclin-dependent kinase 4 inhibitor B, MTS-2, MTS2, Multiple tumor suppressor 2, p14-INK4b, p15-INK4b, p15INK4B
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.

Alternative products to Anti-p15 INK4b Antibody [DCS-114.1] (A280230)

Proteins predicted to interact with p15 INK4b

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.9% Relevancy Score
97.4% Relevancy Score
96.6% Relevancy Score
96.2% Relevancy Score
95.1% Relevancy Score
95.1% Relevancy Score
94.6% Relevancy Score
89% Relevancy Score